Proposed new Medicare regulation on antibiotics that rations care slammed by AAPS

16 August 2016
centers-for-medicare-and-medicaid-services-big

Politically unaccountable groups, having their own agendas, should not be dictating the practice of medicine in the form of guidelines to be required by Medicare, states the Association of American Physicians and Surgeons (AAPS) in comments it submitted on Saturday (August 13) to the Centers for Medicare & Medicaid Services (CMS) on its proposed new regulation.

The proposed regulation would limit the use of antibiotics by physicians and hospitals to prevent disease, deadly and otherwise. It was open for public comment through August 5.

This proposed new rule is CMS-3295-P, innocently entitled "Medicare and Medicaid Programs: Hospital and Critical Access Hospital Changes to Promote Innovation, Flexibility, and Improvement in Patient Care." What this new rule would really do is ration and withhold the use of antibiotics for the tens of millions of patients who are admitted to hospitals, it says.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical